Report: National Strategy to Fight Cancer, 2030 horizon (Portugal)
Go back to Portugal page
Primary purpose: To reduce the incidence of preventable neoplasms, enhance the survival and quality of life of patients, optimize early diagnosis strategies, increase healthcare access equity, support the social and professional reintegration of survivors, and assist caregivers.
Sponsor, manager or home institution: Direção-Geral da Saúde (DGS) and others.
Type of information: Outlines comprehensive strategies for cancer prevention, early detection, diagnosis, treatment, and support for survivors in Portugal through 2030. It details the governance structure, specific objectives, strategic actions, and collaborative efforts across multiple sectors to mitigate cancer incidence and improve patient outcomes. sex, age, number of deaths, year, potential years of life lost, diagnosis, screening, quality of life. Click here to learn more.
Data level: national level.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.
- Forpolicymakers
- Mouth
- Throat
- Oropharynx
- Nasopharynx
- Hypopharynx
- Larynx
- Salivary glands
- Lips
- Tonsils
- Base of the tongue
- Voice box
- Esophagus
- Stomach
- Small intestine
- Large intestine
- Colon
- Rectum
- Anus
- Liver
- Gallbladder
- Bile ducts
- Pancreas
- Lung
- Trachea
- Bronchi
- Pleura
- Mediastinum
- Bone
- Cartilage
- Osteosarcoma
- Ewings sarcoma
- Skin
- Melanoma
- Scalp
- Hands
- Feet
- Muscle
- Fat
- Tendon
- Ligament
- Blood vessels
- Connective tissue
- Sarcoma
- Angiosarcoma
- Liposarcoma
- Lobular
- Breast
- Nipple
- Areola
- Ductal
- Vulva
- Vagina
- Cervix
- Uterus
- Ovary
- Fallopian tubes
- Endometrium
- Prostate
- Testicles
- Penis
- Kidney
- Ureter
- Bladder
- Urethra
- Eye
- Brain
- Spinal cord
- Thyroid gland
- Parathyroid
- Adrenal glands
- Pituitary gland
- Thymus gland
- Peritoneum
- Pericardium
- Retroperitoneum
- Mesothelium
- Blood
- Bone marrow
- Lymph nodes
- Spleen
- Leukemia
